These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33883876)

  • 41. Pharmacokinetics and endometrial effects of the vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women.
    Cicinelli E; Borraccino V; Petruzzi D; Mazzotta N; Cerundolo ML; Schönauer LM
    Fertil Steril; 1996 Apr; 65(4):860-2. PubMed ID: 8654651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A first study to compare two dosages of dydrogesterone in opposing the 50 mg oestradiol implant.
    Rees M; Leather A; Pryse-Davies J; Collins SA; Barlow DH; Studd JW
    Maturitas; 1991 Dec; 14(1):9-15. PubMed ID: 1791775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.
    Foster RH; Balfour JA
    Drugs Aging; 1997 Oct; 11(4):309-32. PubMed ID: 9342560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
    Tournaye H; Sukhikh GT; Kahler E; Griesinger G
    Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 beta-estradiol combined with sequential 5-20 mg dydrogesterone.
    Ferenczy A; Gelfand MM; van de Weijer PH; Rioux JE
    Climacteric; 2002 Mar; 5(1):26-35. PubMed ID: 11974556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Application of Femoston in hormone replacement treatment-frozen embryo transfer and its clinical outcomes].
    Xu W; Zhou F; Li C; Jin XY; Zhu HY; Tong XM; Liu L; Zhang SY
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(47):3766-9. PubMed ID: 24548394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cognitive effects of long-term dydrogesterone treatment used alone or with estrogen on rat menopausal models of different ages.
    Liu J; Lin H; Huang Y; Liu Y; Wang B; Su F
    Neuroscience; 2015 Apr; 290():103-14. PubMed ID: 25637796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
    Schug BS; Donath F; Blume HH
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
    Ruan X; Gu M; Cai G; Zhao Y; Wang L; Li X; Mueck AO
    Maturitas; 2019 May; 123():1-8. PubMed ID: 31027671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17beta-estradiol and norethisterone when compared with an orally administered 17beta-estradiol norethisterone regimen.
    Rozenberg S; Pornel B; Koninckx PR; Palacios S; Christiansen C
    Hum Reprod; 2009 Jul; 24(7):1739-47. PubMed ID: 19351658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there evidence for preferential delivery of ovarian estradiol to the endometrium?
    Tourgeman DE; Boostanfar R; Chang L; Lu J; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2001 Jun; 75(6):1156-8. PubMed ID: 11384642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer.
    Liao X; Li Z; Dong X; Zhang H
    Int J Clin Exp Pathol; 2014; 7(10):6992-7. PubMed ID: 25400786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.
    Miles RA; Paulson RJ; Lobo RA; Press MF; Dahmoush L; Sauer MV
    Fertil Steril; 1994 Sep; 62(3):485-90. PubMed ID: 8062942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of two oral doses of 17beta-estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double-blind placebo-controlled study.
    Rousseau A; Robert A; Gerotziafas G; Torchin D; Zannad F; Lacut K; Libersa C; Dasque E; Démolis JL; Elalamy I; Simon T
    Fundam Clin Pharmacol; 2010 Apr; 24(2):239-45. PubMed ID: 19719551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
    Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
    Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment.
    Massai MR; de Ziegler D; Lesobre V; Bergeron C; Frydman R; Bouchard P
    Fertil Steril; 1993 Jun; 59(6):1179-86. PubMed ID: 8495762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure.
    Bourgain C; Devroey P; Van Waesberghe L; Smitz J; Van Steirteghem AC
    Hum Reprod; 1990 Jul; 5(5):537-43. PubMed ID: 2394784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dehydrogesterone versus vaginal progesterone in the treatment of the endometrial luteal phase deficiency.
    Balasch J; Vanrell JA; Márquez M; Burzaco I; González-Merlo J
    Fertil Steril; 1982 Jun; 37(6):751-4. PubMed ID: 7084497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progesterone administration in patients with absent ovaries.
    Devroey P; Palermo G; Bourgain C; Van Waesberghe L; Smitz J; Van Steirteghem AC
    Int J Fertil; 1989; 34(3):188-93. PubMed ID: 2567713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.